INTRALINE® SPIRAL 29G 50 70 6-0

Product Description

INTRALINE® SPIRAL 29G is a PDO (polydioxanone) thread engineered for precise skin rejuvenation and aesthetic enhancement. These spiral threads feature a unique twisted design that provides superior tissue engagement and optimal lifting capabilities compared to traditional mono threads. The 29G needle gauge ensures accurate placement while minimizing patient discomfort during treatment procedures.

INTRALINE® SPIRAL 29G Dosage and Administration

Treatment protocols vary depending on the specific areas being addressed and the individual patient’s requirements. Practitioners typically insert threads at 1-2 cm intervals, with the number of threads determined by the treatment zone dimensions and the desired lifting intensity.

The recommended insertion depth targets the subcutaneous layer, ensuring optimal mechanical support while avoiding deeper anatomical structures. Thread placement should follow natural facial vectors to achieve harmonious results that complement patient anatomy.

Ingredient Information

The primary component is pharmaceutical-grade polydioxanone, a bioabsorbable polymer with extensive medical applications. This material exhibits excellent biocompatibility and predictable absorption characteristics, typically dissolving completely within 6-8 months after insertion.

The silicone-coated needle enhances smoothness during insertion while reducing friction during thread placement. This coating technology minimizes tissue trauma and improves procedural comfort for patients undergoing treatment.

Storage Instructions

INTRALINE® SPIRAL 29G threads require storage in controlled environmental conditions to maintain product integrity. The recommended storage temperature range is 15°C to 25°C, with protection from direct sunlight and exposure to moisture.

Products should remain in their original packaging until immediately used to prevent contamination and maintain sterility. Avoid exposure to extreme temperatures or freezing conditions that could compromise thread performance characteristics.

INTRALINE® SPIRAL 29G Contraindications

Treatment is contraindicated in patients with active skin infections, autoimmune disorders, or unrealistic expectations regarding treatment outcomes. Pregnant and nursing women should postpone treatment until after completion of breastfeeding.

Patients with known hypersensitivity to polydioxanone or those with bleeding disorders require careful evaluation before treatment consideration. Active inflammatory conditions in the treatment areas represent absolute contraindications to treatment.

INTRALINE® SPIRAL 29G Precautions and Warnings

Practitioners must ensure proper sterile technique throughout the procedure to minimize the risk of infection. A comprehensive patient assessment should include a review of the medical history and setting realistic expectations regarding treatment outcomes and recovery timelines.

Patients taking anticoagulant medications may experience increased bruising and should be counseled accordingly. Post-treatment care instructions must be clearly communicated to ensure optimal healing and achieve the best results.

INTRALINE® SPIRAL 29G Manufacturer and Regulatory Information

INTRALINE® SPIRAL 29G is manufactured by Mecobi Co., Ltd., a leading producer of medical aesthetic devices with comprehensive quality management systems. The product is certified to the CE mark, demonstrating compliance with European medical device regulations and safety standards.

Each batch undergoes rigorous quality control testing to ensure consistent performance and a safe profile. The manufacturer provides complete traceability documentation and technical support for healthcare professionals utilizing these products in their practice.